TLS-CHOP target gene DOL54 expression in liposarcomas and malignant fibrous histiocytomas.
Downstream of the gene for the liposarcoma-associated fusion oncoprotein 54 (DOL54) is a target gene of the myxoid liposarcoma and round cell liposarcoma (M-LPS/RC-LPS) oncogene, TLS/FUS-CHOP. The DOL54 gene product is closely associated with adipogenic differentiation. DOL54 overexpression resulted in tumorigenicity when Chinese Hamster Ovary (CHO) cells were injected subcutaneously into nude mice. The biological significance of DOL54 expression for human malignant soft tissue tumors, however, has not yet been investigated. We examined TLS-CHOP and DOL54 expression in M-LPS/RC-LPS, well-differentiated liposarcoma and malignant fibrous histiocytoma (MFH), a tumor whose cellular origin has not been determined. We observed DOL54 expression in 50% of M-LPS/RC-LPS cases (in which TLS-CHOP was also expressed) and 33% of MFH cases, suggesting that a portion of MFH lesions may either derive from adipocytic precursor cells or have the potential to undergo adipogenic differentiation. In this manner, M-LPS/RC-LPS and MFH lesions may share tumorigenic characteristics, resulting from the unscheduled expression of DOL54.
D015152:Blotting, Northern; D022762:CCAAT-Enhancer-Binding Proteins / Q000096:biosynthesis*; D015972:Gene Expression Regulation, Neoplastic; D018219:Histiocytoma, Benign Fibrous / Q000235:genetics*; D006801:Humans; D008080:Liposarcoma / Q000235:genetics*; D018208:Liposarcoma, Myxoid / Q000235:genetics; D015514:Oncogene Proteins, Fusion / Q000096:biosynthesis*; D034702:RNA-Binding Protein FUS / Q000096:biosynthesis*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D051742:Transcription Factor CHOP
D022762:CCAAT-Enhancer-Binding Proteins; D015514:Oncogene Proteins, Fusion; D034702:RNA-Binding Protein FUS; C106030:TLS-CHOP fusion protein, human; D051742:Transcription Factor CHOP